Original Article
Clinical outcomes of definitive radiotherapy for patients with cT1aN0M0 esophageal cancer unsuitable for endoscopic resection and surgery
Journal of Gastrointestinal Oncology
2022;
13
(2)
:454-461
.
(29 April 2022)
Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(2)
:462-477
.
(29 April 2022)
Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center, single-arm clinical trial (ESONICT-2)
Journal of Gastrointestinal Oncology
2022;
13
(2)
:478-487
.
(29 April 2022)
Predictive model of postoperative pneumonia after neoadjuvant immunochemotherapy for esophageal cancer
Journal of Gastrointestinal Oncology
2022;
13
(2)
:488-498
.
(29 April 2022)
Association between the frequency of tooth brushing and esophageal carcinoma risk: an update systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2022;
13
(2)
:499-509
.
(29 April 2022)
A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(2)
:510-526
.
(29 April 2022)
Comparison of prognostic factors of esophageal cancer between a Chinese cohort and the Surveillance, Epidemiology, and End Results (SEER) database: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:527-538
.
(29 April 2022)
Development and validation of a dual-energy CT-based model to estimate the malignant probability of distal gastric wall thickening
Journal of Gastrointestinal Oncology
2022;
13
(2)
:539-547
.
(29 April 2022)
Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(2)
:548-558
.
(29 April 2022)
Knockdown of tankyrase 1 inhibits the progression of gastric adenocarcinoma via regulating human telomerase reverse transcriptase and telomeric repeat binding factor 1
Journal of Gastrointestinal Oncology
2022;
13
(2)
:559-568
.
(29 April 2022)
Predictive value of prognostic nutritional index on infection after radical gastrectomy: a retrospective study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:569-580
.
(29 April 2022)
Clinical significance and correlation of miR-200c and P-gp expression in gastric cancer and the effects on multidrug resistance
Journal of Gastrointestinal Oncology
2022;
13
(2)
:581-592
.
(29 April 2022)
Identification of the key genes controlling stomach adenocarcinoma stem cell characteristics via an analysis of stemness indices
Journal of Gastrointestinal Oncology
2022;
13
(2)
:593-604
.
(29 April 2022)
The clinical features, management, and survival of elderly patients with gastric cancer
Journal of Gastrointestinal Oncology
2022;
13
(2)
:605-614
.
(29 April 2022)
Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis
Journal of Gastrointestinal Oncology
2022;
13
(2)
:615-629
.
(29 April 2022)
Analysis of the efficacy and safety of paclitaxel (albumin-bound) combined with S-1 and oxaliplatin combined with S-1 in the first-line treatment of advanced gastric cancer: a cohort study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:630-636
.
(29 April 2022)
Value of 18F-FDG PET/CT for differentiating diagnosis between malignant and benign primary gastric gastrointestinal mesenchymal tumors: a single-center retrospective study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:637-646
.
(29 April 2022)
Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(2)
:647-656
.
(29 April 2022)
CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data
Journal of Gastrointestinal Oncology
2022;
13
(2)
:657-671
.
(29 April 2022)
Stage cT3 low rectal cancer: analysis of prognostic factors
Journal of Gastrointestinal Oncology
2022;
13
(2)
:672-682
.
(29 April 2022)
A cross-sectional study of obstructive sleep apnea in patients with colorectal cancer
Journal of Gastrointestinal Oncology
2022;
13
(2)
:683-694
.
(29 April 2022)
miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R/STAT3 pathway in mice
Journal of Gastrointestinal Oncology
2022;
13
(2)
:695-709
.
(29 April 2022)
Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:710-721
.
(29 April 2022)
Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:722-731
.
(29 April 2022)
Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids
Journal of Gastrointestinal Oncology
2022;
13
(2)
:732-743
.
(29 April 2022)
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection
Journal of Gastrointestinal Oncology
2022;
13
(2)
:744-753
.
(29 April 2022)
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression
Journal of Gastrointestinal Oncology
2022;
13
(2)
:754-767
.
(29 April 2022)
Weighted gene co-expression network analysis reveals prognostic and diagnostic significance of PAQR4 in patients with early and late hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(2)
:768-779
.
(29 April 2022)
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:780-786
.
(29 April 2022)
Classification of hepatic cavernous hemangioma or hepatocellular carcinoma using a convolutional neural network model
Journal of Gastrointestinal Oncology
2022;
13
(2)
:787-791
.
(29 April 2022)
Prediction of early recurrence of hepatocellular carcinoma after resection based on Gd-EOB-DTPA enhanced magnetic resonance imaging: a preliminary study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:792-801
.
(29 April 2022)
Influence of schisantherin A on the pharmacokinetics of lenvatinib in rats and its potential mechanism
Journal of Gastrointestinal Oncology
2022;
13
(2)
:802-811
.
(29 April 2022)
Identification of potential prognostic biomarkers for hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2022;
13
(2)
:812-821
.
(29 April 2022)
Biliary cancer brain metastases: a multi-institution case series with case reports
Journal of Gastrointestinal Oncology
2022;
13
(2)
:822-832
.
(29 April 2022)
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:833-846
.
(29 April 2022)
Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration
Journal of Gastrointestinal Oncology
2022;
13
(2)
:847-858
.
(29 April 2022)
Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study
Journal of Gastrointestinal Oncology
2022;
13
(2)
:859-870
.
(29 April 2022)
Review Article
The treatment of resectable gastric cancer: a literature review of an evolving landscape
Journal of Gastrointestinal Oncology
2022;
13
(2)
:871-884
.
(29 April 2022)
Current update of treatment strategies for borderline resectable pancreatic cancer: a narrative review
Journal of Gastrointestinal Oncology
2022;
13
(2)
:885-897
.
(29 April 2022)
Erratum
Erratum to lncRNA POT1-AS1 accelerates the progression of gastric cancer by serving as a competing endogenous RNA of microRNA-497-5p to increase PDK3 expression
Journal of Gastrointestinal Oncology
2022;
13
(2)
:898-902
.
(29 April 2022)
